Nvidia shares reverse after blockbuster earnings meet a wall of investor skepticism — Neutral
NVDA Proactive Investors — November 20, 2025Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) delivered another blockbuster quarter, with demand for its AI chips still running red-hot and its newest Blackwell products selling faster than the company can produce them. Analysts at Bank of America and UBS said the results were so strong that Wall Street will likely need to raise its earnings forecasts for several years out.
LRN INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Stride — Neutral
LRN GlobeNewsWire — November 20, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Stride To Contact Him Directly To Discuss Their Options
MITQ's Q1 Earnings Up Y/Y, Eyes Growth via DCS Audio Expansion — Positive
MITQ Zacks Investment Research — November 20, 2025MiT posts improved margins and a swing to profitability in fiscal Q1. The DCS speaker line acquisition is now a key growth driver as the firm pushes into global cinema audio markets.
MOH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare — Neutral
MOH GlobeNewsWire — November 20, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. (“Molina” or the …
BBB Foods Inc. (TBBB) Q3 2025 Earnings Call Transcript — Neutral
TBBB Seeking Alpha — November 20, 2025BBB Foods Inc. ( TBBB ) Q3 2025 Earnings Call November 20, 2025 11:00 AM EST Company Participants Kamal Hatoum - Founder, CEO & Chairman Eduardo Pizzuto - CFO & Investor Relations Officer Conference Call Participants Robert Ford - BofA Securities, Research Division Joseph Giordano - JPMorgan Chase & Co, Research Division Alvaro Garcia - Banco BTG Pactual S.A., Research Division Alejandro Fuchs - Itaú Corretora de Valores S.A.
Salesforce says some of its customers' data was accessed after Gainsight breach — Negative
CRM TechCrunch — November 20, 2025Salesforce said on Wednesday that it's investigating a breach of “certain customers' Salesforce data” that was compromised through apps published by Gainsight, a company that sells a platform for other companies to manage their customers.
Yum Triples Darden's Margins by Franchising While Darden Buys More Restaurants — Neutral
DRI YUM 24/7 Wall Street — November 20, 2025Darden Restaurants (NYSE: DRI) and Yum!
2 Glass Products Stocks to Ride the Solid Industry Trends — Positive
APOG OI Zacks Investment Research — November 20, 2025Solid end-market demand and focus on unveiling innovative products will aid the Zacks Glass Products industry's growth. This bodes well for stocks like OI and APOG.
Bullish Q3 Earnings and Revenues Improve Year Over Year, Shares Rise — Positive
BLSH Zacks Investment Research — November 20, 2025Bullish posts a sharp Q3 rebound with soaring revenues and a return to profit, lifting shares in pre-market trading.
Venture Global Moves Forward With Plaquemines LNG Expansion Project — Positive
VG Zacks Investment Research — November 20, 2025VG pushes ahead on its Plaquemines LNG expansion, filing key approvals and planning a phased buildout.
Can Stride's 11% Enrollment Growth Outlast Its Platform Glitches? — Positive
LRN Zacks Investment Research — November 20, 2025Stride, Inc. LRN witnessed 11.3% enrollment growth in the first quarter of fiscal 2026, with Career Learning enrollments growing 20% and General Education enrollments improving 5.2%. Its diversified offerings through a career learning platform for areas like healthcare, IT and advanced manufacturing are boosting its prospects.
Will Librexia ACS Study Setback Dent BMY's Cardiovascular Portfolio? — Negative
BMY Zacks Investment Research — November 20, 2025BMY ends its Librexia ACS study after an interim review shows milvexian is unlikely to meet goals, while other late-stage studies continue.
Chevron & TotalEnergies Lead Bidding War for Galp's Namibia Project — Positive
CVX GLPEY TTE Zacks Investment Research — November 20, 2025CVX and TTE are leading the race for Galp's massive Mopane oil stake as Namibia emerges as one of the world's most promising new oil frontiers.
Lineage Stands Ready to Help Customers Seize Market Opportunities as Tariffs on Food Products Roll Back — Neutral
LINE Business Wire — November 20, 2025NOVI, Mich.--(BUSINESS WIRE)-- #onelineage--Lineage, Inc. (NASDAQ: LINE) (the “Company”), the world's largest global temperature-controlled warehouse REIT, has expanded its import and export services to help customers move products in and out of the U.S. with greater confidence and efficiency. As global companies look to adapt to shifting trade conditions, including the rollback of tariffs on more than 200 food products announced last Friday, Lineage's industry-leading network and cold chain expertise enable.
ROSEN, LEADING INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX — Neutral
MLTX Newsfile Corp — November 20, 2025New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline. SO WHAT: If you purchased MoonLake common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
SNPS INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Synopsys — Neutral
SNPS GlobeNewsWire — November 20, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Synopsys To Contact Him Directly To Discuss Their Options
Bill Nygren Isn't Worried About Market Volatility. He Likes GM, Delta, and Capital One. — Positive
COF GM Barrons — November 20, 2025The Oakmark manager said it's still a good time to find bargains, even in some growth stocks.
Final Trades: Alphabet, Starbucks and Welltower — Neutral
GOOG GOOGL SBUX WELL CNBC Television — November 20, 2025The Investment Committee give you their top stocks to watch for the second half.
Jack In The Box: Everything Has Been Priced In, But No Drivers (Downgrade) — Negative
JACK Seeking Alpha — November 20, 2025Jack In The Box, Inc. remains vulnerable to inflationary headwinds with its squeezed sales and margins. Fierce competition with other fast-food chains and even fast-casual diners may continue to hurt its demand and overall performance. The Del Taco sale can open new opportunities for JACK to improve liquidity and profitability.
Uber Eats and Starship to Launch Autonomous Sidewalk Robot Delivery in December — Positive
UBER PYMNTS — November 20, 2025Uber Technologies and Starship Technologies plan to begin rolling out autonomous sidewalk robot delivery for Uber Eats by the end of the year.